Linea Guida - Agenzia di Sanità Pubblica della Regione Lazio

More documents

Recommendations

Info

106 PROFILASSI DELLA TROMBOEMBOLIA VENOSA POST-CHIRURGICA Hamilton HW, Crawford JS, Gardiner JH et al. 1970, Venous thrombosis in patients with fracture of the upper end of the femur: a phlebographic study of the effect of prophylactic anticoagulation, J Bone Joint Surg Br, 52: 268-89. Hamilton MG, Hull RD, Pineo GF 1994, Venous thromboembolism in neurosurgery and neurology patients: a review, J Neurosurg, 34: 280-96. Hammers LW, Cohn SM, Brown JM et al. 1996, Doppler color flow imaging surveillance of deep vein thrombosis in high risk trauma patients, J Ultrasound Med, 15: 19-24. Hamulyak K, Lensing AWA, van der Meer J et al. 1995, Subcutaneous low-molecular weight heparin or oral anticoagulants for the prevention of deep-vein thrombosis in elective hip and knee replacement? Thromb Haemost, 74: 1428-31. Handoll HHG, Farrar MJ, McBirnie J et al. 2002, Heparin, low-molecular-weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures, Cochrane Database Syst Rev; 4:CD000305. Hansson PO, Welin L, Tibblin G, Eriksson H 1997, Deep vein thrombosis and pulmonary embolism in the general population. The Study of Men Born in 1913, Arch Intern Med, Aug 11-25, 157: 1665-70. Harris LM, Curl GR, Booth FV et al. 1997, Screening for asymptomatic deep vein thrombosis in surgical intensive care patients, J Vasc Surg, 26: 764-9. Headrick JR, Barker DE, Pate LM et al. 1997, The role of ultrasonography and inferior vena cava filter placement in high-risk trauma patients, Am Surg, 63: 1-8. Hedlund PO 1975, Postoperative venous thrombosis in benign prostatic disease: a study of 316 patients, using the 125I-fibrinogen uptake test, Scand J Urol Nephrol (suppl), 27: 1-100. Hedlund PO, Blomback M 1981, The effects of low-dose heparin treatment on patients undergoing transvesical prostatectomy, Urol Res, 9: 147-52. Hefley WF, Nelson CL, Puskarich-May CL 1996, Effect of delayed admission to the hospital on the preoperative prevalence of deep-vein thrombosis associated with fractures about the hip, J Bone Joint Surg Am, 78: 581-3. Heilmann L, von Tempelhoff GF, Schneider D 1998, Prevention of thrombosis prophylaxis in gynecologic malignancy, Clin Appl Thromb Hemost, 4: 153-9. Heinzer H, Hammerer P, Graefen M et al. 1998, Thromboembolic complication rate after radical retropubic prostatectomy: impact of routine ultrasonography for the detection of pelvic lymphoceles and hematomas, Eur Urol, 33: 86-90. Heit JA, Berkowitz SD, Bona R et al. 1997, Efficacy and safety of low-molecularweight heparin (ardeparin sodium) compared to warfarin for the prevention of
BIBLIOGRAFIA venous thromboembolism after total knee replacement surgery: a doubleblind, dose-ranging study, Thromb Haemost, 77: 32-8. Heit JA, Colwell CW, Francis CW et al. 2001, Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement: a phase 2 dose-finding study, Arch Intern Med, 161: 2215-21. Heit JA, Silverstein MD, Mohr DN et al. 2001, The epidemiology of venous thromboembolism in the community, Thromb Haemost, 86: 452-63. Heit JA, Rooke TW, Silverstein MD et al. 2001, Trends in the incidence of venous stasis syndrome and venous ulcer: a 25-year population-based study, J Vasc Surg, 33: 1022-7. Heit J, Neemeh J, Hyers T et al. 1991, Operating characteristics of cuff impedance plethysmography in the diagnosis of deep-vein thrombosis following total hip or knee arthroplasty [abstract], Blood, 78 (suppl): 214a. Hendolin H, Mattila MAK, Poikolainen E 1981, The effect of lumbar epidural analgesia on the development of deep vein thrombosis of the legs after open prostatectomy, Acta Chir Scand, 147: 425-9. Hirsch DR, Ingenito EP, Goldhaber SZ 1995, Prevalence of deep venous thrombosis among patients in medical intensive care, JAMA, 274: 335-7. Hjelmstedt A, Bergvall U 1968, Incidence of thrombosis in patients with tibial fractures: a phlebographic study, Acta Chir Scand, 134: 209-18. Hoek JA, Nurmohamed MT, Hamelynck KJ et al. 1992, Prevention of deep vein thrombosis following total hip replacement by low-molecular-weight heparinoid, Thromb Haemost, 67: 28-32. Hollyoak M, Woodruff P, Muller M et al. 2001, Deep venous thrombosis in postoperative vascular surgical patients: a frequent finding without prophylaxis, J Vasc Surg, 34: 656-60. Horlocker TT, Heit JA 1997, Low-molecular-weight heparin: biochemistry, pharmacology, perioperative prophylaxis regimens, and guidelines for regional anaesthetic management, Anaesth Analg, 85: 874-85. Horlocker TT, Wedel DJ 1998, Neuraxial block and low-molecular-weight heparin: balancing perioperative analgesia and thromboprophylaxis, Reg Anaesth Pain Med, 23: 164-77. Horlocker TT, Wedel DJ, Benzon H et al. 2003, Regional anaesthesia in the anticoagulated patient: defining the risks (The Second ASRA Consensus Conference on Neuraxial Anaesthesia and Anticoagulation), Reg Anaesth Pain Med, 28: 172-97. 107
Page 1 and 2:
LAZIOSANITÀ - AGENZIA DI SANITÀ P
Page 3 and 4:
Indice p. 6 Il Gruppo di Lavoro 9 1
Page 5 and 6:
p. 69 8. Traumi Raccomandazioni 72
Page 7 and 8:
Prof. Raffaele Landolfi Professore
Page 9 and 10:
10 PROFILASSI DELLA TROMBOEMBOLIA V
Page 11 and 12:
Page 13 and 14:
Page 16 and 17:
2. Metodi di sviluppo della Linea G
Page 18 and 19:
- exp heparin, low-molecular-weight
Page 20 and 21:
METODI DI SVILUPPO DELLA LINEA GUID
Page 22 and 23:
- pubblicazioni scientifiche; - pre
Page 24 and 25:
3. I fattori di rischio per la trom
Page 26 and 27:
I FATTORI DI RISCHIO PER LA TROMBOE
Page 28 and 29:
4. Metodi per la profilassi Di segu
Page 30 and 31:
METODI PER LA PROFILASSI to risulta
Page 32 and 33:
METODI PER LA PROFILASSI Raccomanda
Page 34:
Eparine a basso peso molecolare. Le
Page 37 and 38:
Page 39 and 40:
Nome e anno Mismetti 2001 Koch 2001
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 48 and 49:
6. Chirurgia vascolare 6.1. Chirurg
Page 50 and 51:
7. Chirurgia ortopedica e neurochir
Page 52 and 53:
considerati nella LG dell’ACCP, s
Page 54 and 55: 7.1.3. Profilassi farmacologica CHI
Page 56 and 57: CHIRURGIA ORTOPEDICA E NEUROCHIRURG
Page 62 and 63: 7.6. Durata della profilassi CHIRUR
Page 66 and 67: dell’ACCP, settima revisione (Gee
Page 68 and 69: 8. Traumi I pazienti politraumatizz
Page 70 and 71: ati di contenzione (Greenfield 1997
Page 72 and 73: TRAUMI degli arti inferiori ed il r
Page 74 and 75: 9. Farmaci antitrombotici ed aneste
Page 76 and 77: FARMACI ANTITROMBOTICI ED ANESTESIA
Page 78 and 79: 10. Terapia intensiva I pazienti ch
Page 80 and 81: 11. Pazienti con malattia oncologic
Page 82: Sintesi per i pazienti I pazienti c
Page 86 and 87: A. Indagini diagnostiche di screeni
Page 88 and 89: B. Elenco delle principali Linee Gu
Page 90 and 91: 92 PROFILASSI DELLA TROMBOEMBOLIA V
Page 98 and 99: 100 PROFILASSI DELLA TROMBOEMBOLIA
show all

Linea Guida - Agenzia di Sanità Pubblica della Regione Lazio

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?